HIV and HCV among drug users and people living in prisons in Germany 2022: WHO elimination targets as reflected in practice

• Main Authors: H. Stöver (Author), A. Dichtl (Author), D. Schäffer (Author), M. Grabski (Author)
• Format: Book
• Published: BMC, 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 10.1186/s12954-023-00774-1; 1477-7517
• Keywords: HIV; HCV; WHO elimination targets; Key populations; Prison; Public aspects of medicine; RA1-1270
• Source: Harm Reduction Journal, Vol 20, Iss 1, Pp 1-8 (2023)

Abstract People who inject drugs (PWID) and prisoners are considered key populations at risk for human immunodeficiency virus (HIV) and/or Hepatitis C Virus (HCV). In 2016, the Joint United Nations Program on HIV/AIDS (UNAIDS) was implemented to eliminate HIV and AIDS by 2030 and the World Health Organization (WHO) presented the first strategy to eliminate viral hepatitis by 2030 as well. Following the objectives of the WHO and the United Nations, the German Federal Ministry of Health (BMG) presented the first integrated overall strategy for HIV and HCV in 2017. This article discusses the situation of PWID and prisoners in Germany with regard to HIV and HCV five years after the adoption of this strategy, on the basis of available data and against the background of the most recent practice in the field. In order to meet the elimination goals by 2030, Germany will have to improve the situation of PWID and prisoners substantially, mainly through the implementation of evidence-based harm reduction measures as well as the promotion of diagnosis and treatment in prisons and in freedom.